Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study

Author:

Asif Kaiz S.12ORCID,Otite Fadar O.3ORCID,Desai Shashvat M.4ORCID,Herial Nabeel5ORCID,Inoa Violiza6,Al-Mufti Fawaz7ORCID,Jadhav Ashutosh P.8ORCID,Dmytriw Adam A.9ORCID,Castonguay Alicia10ORCID,Khandelwal Priyank11ORCID,Potter-Vig Jennifer12,Szeder Viktor13ORCID,Kulman Tanzila14,Urrutia Victor15ORCID,Masoud Hesham16ORCID,Toth Gabor17ORCID,Limaye Kaustubh18ORCID,Aroor Sushanth19,Brinjikji Waleed20ORCID,Rai Ansaar21ORCID,Pandian Jeyaraj22ORCID,Gebreyohanns Mehari23,Leung Thomas24ORCID,Mansour Ossama25ORCID,Demchuk Andrew M.26ORCID,Huded Vikram27,Martins Sheila28ORCID,Zaidat Osama29ORCID,Huo Xiaochuan30ORCID,Campbell Bruce31ORCID,Sylaja P.N.23,Miao Zhongrong30ORCID,Saver Jeffrey13ORCID,Ortega-Gutierrez Santiago32ORCID,Yavagal Dileep R.33ORCID,Cirio Juan Jose,Lylyk Pedro,Ferrario Angel,Plaghos Luis Lemme,Arroyo José,Yan Bernard,Chandra Ronil,Ibrahim Wael Hamed,Alnidawi Firas,Islam Sirajee Shafiqul,Shahidullah Mohammad,Saavedra Víctor Villarroel,Alverne Francisco Josà Mont’,Magalhaes Pedro,Silva Gisele Sampaio,Sirakov Stanimir,Kalpachki Rosen,Alioski Nurfet,lamou Eric Gueumekane bila,Shankar Jai,Stotts Grant,Rowe Daidre,Gayle Francene,de Souza Romnesh,Ramos Cristina,GarcÃa Amaury,Ali Amza,Sandy Sherry,Lavados Pablo M.,Rivera Rodrigo,GUZMÁN TONY FABIÁN ÁLVAREZ,Villarraga Alejandro,Estrada Carolina,Pabon Boris,Krajina Antonin,Tomek Aleš,Adebayo Philip B,ABDO GERMAN,Maldonado S Nelson,Hassan Farouk,Khedr Eman M,Khinikadze Mirza,NADAREISHVILI ZURAB,Tsiskaridze Alexander,Syrmos Nikolaos,Mitsias Panayiotis,Das Biplab,Roy Jayanta,Gupta Vivek,Gupta Vipul,Khurana Dheeraj,Karapurkar Anil,Stivastava M.V.Padma,Alurkar Anand,Sharma Arvind,Lahoti Satish,Kumar Rahul,Kuruttukulam Gigy Varkey,Sani Achmad Firdaus,Sari Ita Muharram,Khassaf Mustafa,Majid Nassir Temeem,Sakai Nobuyuki,Yamagami Hiroshi,Dababneh Haitham,Aladham Farid A.,Berdikhojayev Mynzhylky,Medukhanova Sabina,Kikano Raghid,Alaraj Ali,Ahdab Rechdi,Zaidi Wan Asyraf Wan,Kadir Khairul Azmi Abd,Arauz Antonio,Gongora Fernando,Jambaldorj Ariunaa,XXX Ganbaatar,Shwe Zarni Myint,Thit Win Min,Ranta Anna,Wu Teddy,RAYO ERWIN E.,Owolabi Mayowa,Makanjuola Akintomiwa,Ahmad Saima,WASAY MOHAMMAD,Rashid Umair,Mernes Ricardo,Paniagua Osvaldo,GALLO MARLA,Moquillaza Manuel,Collantes Maria Epifania,Mariano Manuel M.,Kobayashi Adam,Rodriguez-Mercado Rafael,Guardia Rodolfo Alcedo,Imam Yahia,Ahmed Ayman Zakaria,Alhazzani Adel,Al-Jehani Hosam M.,Lee Wickly,ZELEŇÁK Kamil,Klepanec Andrej,KRASTEV GEORGI,Frol Senta,Brey Naeem,Rossouw Anastasia,De Silva Prasad,Gunasekera Harsha,Ranawaka Udaya,Osman Haytham,El-Sadig Sarah M,Suwanwela Nijasri C.,Akarathanawat Wasan,Tantivatana Jarturon,Hammami Nadia,Sassi Samia Ben,Ozdemir Atilla Ozcan,Giray Semih,Lebedynets Dmytro,Konotopchik Stanislav,John Seby,Hussain Syed Irteza,Novakovic-White Robin,Ozdemir Atilla Ozcan,Giray Semih,Gordon Perue Gillian L.,Then Ryna,Berrutti Claudio,Crosa Roberto,Nguyen Huy Thang,Le Huynh Vu,vu Tran thanh

Affiliation:

1. Ascension Health, Chicago, IL (K.S.A.).

2. University of Illinois, Chicago (K.S.A.).

3. SUNY Upstate Medical University, Syracuse, NY (F.O.O.).

4. HonorHealth Research and Innovation Institute, Scottsdale, AZ (S.M.D.).

5. Thomas Jefferson University, Philadelphia, PA (N.H.).

6. Semmes-Murphey Neurologic and Spine Clinic, Memphis, TN (V.I.).

7. New York Medical College, Valhalla, NY (F.A.-M.).

8. Barrow Neurological Institute, Phoenix, AZ (A.P.J.).

9. Massachusetts General Hospital, Boston (A.A.D.).

10. University of Toledo, OH (A.C.).

11. Rutgers New Jersey Medical School, Newark (P.K.).

12. Society of Vascular and Interventional Neurology/MT2020, University of Illinois, Springfield, IL (J.P.-V.).

13. University of California, Los Angeles (V.S., J.S.).

14. Aultman Hospital, Canton, OH (T.K.).

15. Johns Hopkins University School of Medicine, Baltimore, MD (V.U.).

16. State University of New York, Syracuse (H.M.).

17. Cleveland Clinic, OH (G.T.).

18. Indiana University, Bloomington (K.L.).

19. Rutgers University, Newark, NJ (S.A.).

20. Mayo Clinic, Rochester, MN (W.B.).

21. West Virginia University, Morgantown (A.R.).

22. Christian Medical College, Vellore, India (J.P.).

23. University of Texas Southwestern Medical Center, Dallas (M.G.).

24. Prince of Wales Hospital, Randwick, Australia (T.L.).

25. Alexandria University, Egypt (O.M.).

26. Calgary Stroke Program, Canada (A.M.D.).

27. NH Institute of Neurosciences, Bengaluru, Karnataka, India (V.H.).

28. University of Rio Grande do Sul, Porto Alegre, Brazil (S.M.).

29. St Vincent Mercy Medical Center, Toledo, OH (O.Z.).

30. Beijing Tiantan Hospital, Capital Medical University, Beijing, China (X.H., Z.M.).

31. Royal Melbourne Hospital, University of Melbourne, Parkville, Australia (B.C.).

32. University of Iowa, Iowa City (S.O.-G.).

33. University of Miami Miller School of Medicine, FL (D.R.Y.).

Abstract

Background: Despite the well-established potent benefit of mechanical thrombectomy (MT) for large vessel occlusion (LVO) stroke, access to MT has not been studied globally. We conducted a worldwide survey of countries on 6 continents to define MT access (MTA), the disparities in MTA, and its determinants on a global scale. Methods: Our survey was conducted in 75 countries through the Mission Thrombectomy 2020+ global network between November 22, 2020, and February 28, 2021. The primary end points were the current annual MTA, MT operator availability, and MT center availability. MTA was defined as the estimated proportion of patients with LVO receiving MT in a given region annually. The availability metrics were defined as ([current MT operators×50/current annual number of estimated thrombectomy-eligible LVOs]×100 = MT operator availability) and ([current MT centers×150/current annual number of estimated thrombectomy-eligible LVOs]×100= MT center availability). The metrics used optimal MT volume per operator as 50 and an optimal MT volume per center as 150. Multivariable-adjusted generalized linear models were used to evaluate factors associated with MTA. Results: We received 887 responses from 67 countries. The median global MTA was 2.79% (interquartile range, 0.70–11.74). MTA was <1.0% for 18 (27%) countries and 0 for 7 (10%) countries. There was a 460-fold disparity between the highest and lowest nonzero MTA regions and low-income countries had 88% lower MTA compared with high-income countries. The global MT operator availability was 16.5% of optimal and the MT center availability was 20.8% of optimal. On multivariable regression, country income level (low or lower–middle versus high: odds ratio, 0.08 [95% CI, 0.04–0.12]), MT operator availability (odds ratio, 3.35 [95% CI, 2.07–5.42]), MT center availability (odds ratio, 2.86 [95% CI, 1.84–4.48]), and presence of prehospital acute stroke bypass protocol (odds ratio, 4.00 [95% CI, 1.70–9.42]) were significantly associated with increased odds of MTA. Conclusions: Access to MT on a global level is extremely low, with enormous disparities between countries by income level. The significant determinants of MT access are the country’s per capita gross national income, prehospital LVO triage policy, and MT operator and center availability.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3